(Q45840083)

16 December 2017

title

Absence of pre-S2 antibodies in natural hepatitis B virus infection (English)

1 reference

16 December 2017

1 reference

U Hellström

1

1 reference

16 December 2017

S Sylvan

series ordinal

2

1 reference

16 December 2017

M Kuhns

series ordinal

3

1 reference

16 December 2017

V Sarin

series ordinal

4

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 October 1986

1 reference

16 December 2017

published in

The Lancet

1 reference

16 December 2017

volume

2

1 reference

16 December 2017

issue

8512

1 reference

16 December 2017

page(s)

889-893

1 reference

16 December 2017

Human serum albumin and the enigma of chronic hepatitis type B.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

An Antibody Which Precipitates Dane Particles in Acute Hepatitis Type B: Relation to Receptor Sites Which Bind Polymerized Human Serum Albumin on Virus Particles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Hepatitis B vaccines with pre-S gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Solid-phase sequencing on the gas-phase sequencer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Transferrin can replace serum forin vitro growth of mitogen-stimulated T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Hepatitis B virus contains pre-S gene-encoded domains

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Detection of antibodies directed against the pre-S gene product of hepatitis B virus: relationship between anti-pre-S response and recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Demonstration of albumin receptors onisolated human hepatocytes by light and scanning electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Albumin binding sites of human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Enzyme-linked immunoassay of pre-S gene-coded sequences in hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Sites that bind polymerized albumin on hepatitis B surface antigen particles: detection by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Antibody to hepatitis B surface antigen may not always indicate immunity to hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Low immune responses to hepatitis B vaccination among healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Hepatitis B vaccination: how long does protection last?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Hepatitis B vaccine with and without polymerised albumin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Antibody responses to recombinant and plasma derived hepatitis B vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Human hepatitis B vaccine from recombinant yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Should pre-S coded peptides be used in hepatitis B vaccines?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

Protection against hepatitis B virus infection by immunization with hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2990412-5

7 January 2021

10.1016/S0140-6736(86)90412-5

Identifiers

DOI

1 reference

16 December 2017

PubMed ID

2876328

1 reference

16 December 2017